Add Company
Join Now

NeuroSigma Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • NeuroSigma has 6 Employees.(i)
  • NeuroSigma grew their employee count by 0% last year.

NeuroSigma's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Medical Officer and SVPReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
VP Financial PlanningReveal Email/Phone
6
VP Finance & OperationsReveal Email/Phone
7
Director EngineeringReveal Email/Phone
8
Operations ManagerReveal Email/Phone
9
Dir Advanced MaterialsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A8-27%N/AN/A
#2
$1.7M336%N/AN/A
#3
N/A1645%N/AN/A
#4
$1.7M40%$1.7MN/A
#5
$7.5M240%N/AN/A
#6
N/A60%N/AN/A
#7
N/A2-92%N/AN/A
#8
N/A70%N/AN/A
#9
N/A8922%N/AN/A
#10
N/A3314%N/AN/A
Add Company

What Is NeuroSigma?

NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS® System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD. The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.

keywords:N/A

N/A

Total Funding

6

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M6N/AN/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.4M6N/AN/A